All Miami Cancer Institute | Miami Cancer Institute | Baptist Health South Florida

Menu

Skip to main content

All Miami Cancer Institute

Submissions from 2024 2024

Radiotherapy Plan Quality Assurance in NRG Oncology Trials for Brain and Head/Neck Cancers: An AI-Enhanced Knowledge-Based Approach, Minesh Mehta

Implications and interchangeability of meningioma biomarkers for clinical trials and clinical practice, Minesh Mehta

Comparative evaluation of the diagnostic and prognostic performance of CNSide™ versus standard cytology for leptomeningeal disease, Haley Appel, Muni Rubens, Mukesh Roy, Rupesh Kotecha, Matthew Hall, Minesh Mehta, Zhijian Chen, Manmeet Ahluwalia, and Yazmin Odia

Outpatient administration of CAR T-cell therapy: a focused review with recommendations for implementation in community based centers, Ariel Perez, Tiba Al Sagheer, George Nahas, and Yuliya Linhares

A practical method of estimating medium-heterogeneity corrected dose without a Monte Carlo calculation in ocular brachytherapy using (125)I COMS plaques, Cecilia Lee

Diffuse midline glioma, H3K27-altered: Illuminating the dark side of the moon, Yazmin Odia

Evaluating the heterogeneity of hippocampal avoidant whole brain radiotherapy treatment effect: A secondary analysis of NRG CC001, Minesh Mehta

Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma, Yazmin Odia, Doured Daghistani, and Matthew Hall

Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort, Yazmin Odia and Matthew Hall

Diagnostic terminology for benign/low-risk tumors on renal cytology, Andrew Renshaw

In Reply to Cellini and Fiore, Michael Chuong

Intersection of Race and Gender in the Cardiothoracic Workforce: Study of Representation and Salary, Ian Bostock

ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma, Yazmin Odia and Minesh Mehta

ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma, Yazmin Odia and Minesh Mehta

Predicting the Effect of Proton Beam Therapy Technology on Pulmonary Toxicities for Patients With Locally Advanced Lung Cancer Enrolled in the Proton Collaborative Group Prospective Clinical Trial, Rupesh Kotecha

Prophylactic abdominal drainage after distal pancreatectomy (PANDORINA): an international, multicentre, open-label, randomised controlled, non-inferiority trial, Horacio Asbun

Zavegepant for Acute Treatment of Migraine: A Systematic Review and Meta-analysis of Randomized Controlled Trials, Mainak Bardhan

Push/Pull Assignement Methodology, Danielle Miller

Integrative Bioinformatics-Gene Network Approach Reveals Linkage between Estrogenic Endocrine Disruptors and Vascular Remodeling in Peripheral Arterial Disease, Venkataraghavan Ramamoorthy and Muni Rubens

First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors, Bruno Bastos

Adverse Outcomes among Hospitalizations for Amyloid-Related Heart Failure, Zhenwei Zhang, Md Ashfaq Ahmed, Mukesh Roy, Venkataraghavan Ramamoorthy, Anshul Saxena, Muni Rubens, Sandra Chaparro, and Javier Jimenez

Analysis of Hospital Outcomes in Patients Admitted with Pulmonary Hypertension Caused by Interstitial Lung Diseases, Zhenwei Zhang, Yanija Zhang, Md Ashfaq Ahmed, Venkataraghavan Ramamoorthy, Mukesh Roy, Anshul Saxena, Muni Rubens, Sandra Chaparro, and Javier Jimenez

Assessment of Appropriate Anticoagulation in Multiple Myeloma Patients- a Health System Specialty Pharmacy Retrospective Evaluation, Addie Planas, Beatriz Jimenez-Cadilla, Brittany Alvarez, Cristina Vargas, Jacqualine Igwe, Karina Gonzalez-Jacobo, Maria Pulido, and Michelle Linh Le

Beyond "C": A Nurse Navigator-Led Education Project to Increase Survivorship Referrals and Cancer Survivorship Attendance, Carem Costa, Natalie Bermudez, Pamela DeLongchamp, Luz Morales, Tania Silva Santos, Merly Alonso, Barbara Quintana, Morgan Nestingen, and Marguerite Rowell

Evaluating a Novel Patient Intake Model for Newly Referred Patients Seeking Cancer Care: An Evidence-Based Practice Project, Roquinna Serna, Stella Fernandez, Morgan Nestingen, and Stephen Breazeale